TE_56
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | L1MB8_3end |
---|---|
TE superfamily | L1 |
TE class | LINE |
Gene | ACOT7 |
Class | Chimeric |
Coding | Non-coding |
Tumor-specific score | 10.26 |
Counts of samples | TCGA_tumor:254; TCGA_normal:1; GTEx:26 |
TSS | chr1(-):6295302 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_56.1 | ACOT7 | Chimeric | Non-coding | Non-coding | chr1(-):6264675,6264695,6281102,6281286,6294864,6294980,6295249,6295303 |
teRNA_56.2 | ACOT7 | Chimeric | Non-coding | Non-coding | chr1(-):6264675,6264695,6281102,6281286,6282724,6282796,6294864,6294980,6295249,6295303 |
teRNA_56.3 | ACOT7 | Chimeric | Non-coding | Non-coding | chr1(-):6264675,6264695,6281102,6281286,6282724,6282888,6294864,6294980,6295249,6295303 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.